Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Universal Genomic Newborn Screening in the Wallonia-Brussels Federation: Baby Detect

NCT05687474 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Liege as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05687474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Universal Genomic Newborn Screening in the Wallonia-Brussels Federation: Baby Detect
Lead sponsor
Centre Hospitalier Universitaire de Liege
Phase
Observational
Overall status
Completed
Start date
September 1, 2022
Completion date
June 2, 2025
Enrollment
6,824 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

3-hydroxy 3-methyl glutaric aciduria, 3-hydroxy-3-methylglutaryl-coa synthase 2 deficiency, aciduria, argininosuccinic, acyl-coa dehydrogenase family, member 9, deficiency of, adrenoleukodystrophy, alpha 1-antitrypsin deficiency, alpha-thalassemia, alport syndrome, andersen tawil syndrome, argininemia, aromatic l-amino acid decarboxylase deficiency, ataxia with vitamin e deficiency, beta ketothiolase deficiency, biotinidase deficiency, brain dopamine-serotonin vesicular transport disease, branched-chain keto acid dehydrogenase kinase deficiency, carbamoyl phosphate synthase 1 deficiency, carnitine acylcarnitine translocase deficiency, carnitine palmitoyltransferase deficiency 1, carnitine palmitoyltransferase deficiency 2, catecholaminergic polymorphic ventricular tachycardia, cerebral folate transport deficiency, charcot-marie-tooth disease, type 6c, chediak-higashi syndrome, chronic granulomatous disease, citrullinemia 1, citrullinemia type ii, cobalamin deficiency, congenital adrenal hyperplasia, congenital hypothyroidism, congenital myasthenic syndrome, congenital nephrotic syndrome, finnish type, creatine deficiency syndrome, crigler-najjar syndrome, cystic fibrosis, cystinosis, deficiency of got2, deficit in anterior pituitary function and variable immunodeficiency, diamond blackfan anemia, disaccharide intolerance i, dopamine beta hydroxylase deficiency, familial chylomicronemia, familial hemophagocytic lymphocytosis, familial hyperinsulinemic hypoglycemia 1, familial hypertrophic cardiomyopathy type 4, fanconi anemia, fanconi bickel syndrome, fructose-1,6-diphosphatase deficiency, fructosemia, galactosemias, gaucher disease, type 1, glucose 6 phosphate dehydrogenase deficiency, glucose galactose malabsorption, glut1 deficiency syndrome, glutaric acidemia i, glycine encephalopathy, glycogen storage disease, griscelli syndrome, hemophilia a, hemophilia b, hereditary hyperekplexia, hereditary nephrogenic diabetes insipidus, hereditary retinoblastoma, holocarboxylase synthetase deficiency, homocystinuria, hyperornithinemia-hyperammonemia-homocitrullinuria, hypophosphatasia, infantile, inflammatory bowel disease 25, autosomal recessive, isolated methylmalonic acidemia, isovaleric acidemia, jervell-lange nielsen syndrome, late-infantile neuronal ceroid lipofuscinosis, long-chain 3-hydroxyacyl-coa dehydrogenase deficiency, lysosomal acid lipase deficiency, malonic acidemia, maple syrup urine disease, maturity onset diabetes of the young, medium chain acyl coa dehydrogenase deficiency, menkes disease, metachromatic leukodystrophy, mucopolysaccharidosis i, mucopolysaccharidosis ii, mucopolysaccharidosis iv a, mucopolysaccharidosis vi, mucopolysaccharidosis vii, n acetyl glutamate synthetase deficiency, ornithine transcarbamylase deficiency, phenylalanine hydroxylase deficiency, phosphoglucomutase 1 deficiency, phosphoglycerate dehydrogenase deficiency, phosphoserine aminotransferase deficiency, phosphoserine phosphatase deficiency, pituitary hormone deficiency, combined, pompe disease, primary hyperoxaluria, progressive familial intrahepatic cholestasis, propionic acidemia, pseudohypoaldosteronism type 1, pseudohypoaldosteronism, type ii, pyridoxine-5'-phosphate oxidase deficiency, pyridoxine-dependent epilepsy, riboflavin deficiency, riboflavin transporter deficiency, s-adenosylhomocysteine hydrolase deficiency, segawa syndrome, autosomal recessive, sepiapterin reductase deficiency, severe combined immune deficiency, severe congenital neutropenia, shwachman-diamond syndrome, sickle cell disease, smith-lemli-opitz syndrome, succinyl-coa:3-ketoacid coa-transferase deficiency, systemic primary carnitine deficiency, thiamine metabolism dysfunction syndrome 2, thiamine metabolism dysfunction syndrome 4 (bilateral striatal degeneration and progressive polyneuropathy type), thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type), thiamine-responsive megaloblastic anemia, timothy syndrome, transcobalamin deficiency, tyrosinemia, type i, very long chain hydroxy acyl dehydrogenase deficiency, wilson disease, wiskott-aldrich syndrome, x linked hypophosphatemia